American Research & Management Co. Abb Vie Inc. Transaction History

American Research & Management Co.

$362 Million
Q3 2022

A detailed history of American Research & Management Co. transactions in Abb Vie Inc. stock. As of the latest transaction made, American Research & Management Co. holds 2,654 shares of ABBV stock, worth $477,720. This represents 0.1% of its overall portfolio holdings.

Number of Shares

2,654

Previous 2,654 -0.0%

Holding current value

$477,720

Previous $406,000 12.32%

% of portfolio

0.1%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $10,321 - $13,122	-75 Reduced 2.75%	2,654 $406,000
Q1 2022 Apr 21, 2022	SELL	$131.98 - $163.75 $26,923 - $33,405	-204 Reduced 6.96%	2,729 $442,000
Q4 2021 Jan 28, 2022	BUY	$107.43 - $135.93 $2,363 - $2,990	22 Added 0.76%	2,933 $397,000
Q3 2021 Oct 28, 2021	SELL	$106.4 - $120.78 $21,280 - $24,156	-200 Reduced 6.43%	2,911 $314,000
Q2 2021 Jul 16, 2021	BUY	$105.21 - $117.21 $57,865 - $64,465	550 Added 21.48%	3,111 $350,000
Q1 2021 Apr 06, 2021	SELL	$102.3 - $112.62 $66,699 - $73,428	-652 Reduced 20.29%	2,561 $277,000
Q4 2020 Jan 28, 2021	BUY	$80.49 - $108.67 $80 - $108	1 Added 0.03%	3,213 $344,000
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $10,738 - $12,603	-125 Reduced 3.75%	3,212 $281,000
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $3,668 - $4,909	-50 Reduced 1.48%	3,337 $328,000
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $3,225 - $4,889	-50 Reduced 1.45%	3,387 $258,000
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $10,819 - $13,537	-150 Reduced 4.18%	3,437 $304,000
Q3 2019 Oct 31, 2019	BUY	$62.98 - $75.72 $6,298 - $7,572	100 Added 2.87%	3,587 $272,000
Q2 2019 Jul 18, 2019	SELL	$65.7 - $83.98 $6,570 - $8,398	-100 Reduced 2.79%	3,487 $254,000
Q1 2019 Apr 16, 2019	BUY	$77.14 - $90.79 $157,134 - $184,939	2,037 Added 131.42%	3,587 $289,000
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $7,784 - $9,601	-100 Reduced 6.06%	1,550 $143,000
Q3 2018 Oct 04, 2018	SELL	$88.91 - $98.84 $8,891 - $9,884	-100 Reduced 5.71%	1,650 $156,000
Q2 2018 Jul 25, 2018	SELL	$89.78 - $106.23 $9,606 - $11,366	-107 Reduced 5.76%	1,750 $162,000
Q1 2018 Apr 19, 2018	SELL	$92.01 - $123.21 $12,881 - $17,249	-140 Reduced 7.01%	1,857 $176,000
Q4 2017 Feb 08, 2018	BUY	$89.56 - $98.21 $9,851 - $10,803	110 Added 5.83%	1,997 $193,000
Q3 2017 Oct 17, 2017	BUY	$69.85 - $89.22 $131,806 - $168,358	1,887	1,887 $168,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Research & Management Co., based on Form 13F filings with the SEC.

News

Stay updated on American Research & Management Co. with notifications on news.

Account

American Research & Management Co. Abb Vie Inc. Transaction History